Genetic Signatures Revenue
Biotechnology Research • 
Sydney, New South Wales, Australia • 101-200 Employees
Genetic Signatures revenue & valuation
| Annual revenue | $11,300,000 |
| Revenue per employee | $108,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $35,900,000 |
| Total funding | No funding |
Key Contacts at Genetic Signatures
Sarah Peaty
Head of Sales and Support, North America, Australia & New Zealand
Company overview
| Headquarters | 7 Eliza St, Newtown, New South Wales 2042, AU |
| Phone number | +61298707580 |
| Website | |
| NAICS | 541714 |
| SIC | 873 |
| Keywords | Molecular Diagnostics, Pathogen Detection, Real-Time Pcr, 3Base Technology, Enteric Pathogen Detection, Infectious Disease Detection |
| Founded | 2001 |
| Employees | 101-200 |
| Socials |
Genetic Signatures Email Formats
Genetic Signatures uses 2 email formats. The most common is {first name}.{last name} (e.g., john.doe@geneticsignatures.com), used 79.7% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@geneticsignatures.com | 79.7% |
{first initial}.{last name} | j.doe@geneticsignatures.com | 20.3% |
About Genetic Signatures
Genetic Signatures is an established, global molecular diagnostics company, specialising in syndromic multiplex real-time PCR testing to provide configurable, clinically relevant MDx solutions for infectious diseases. A diverse range of assays are available under the EasyScreen™ brand, for the flexible detection of over 100 pathogens impacting global health. The EasyScreen™ kits are underpinned by Genetic Signatures’ innovative 3base™ technology, which transforms natural genetic sequences into a 3base™ sequence of A, T and C which improves multiplex efficiency and reduces the genetic complexity of detecting pathogens. This is particularly beneficial for detecting pathogen subtypes and providing increased resistance to mutation or variants, such as SARS-CoV-2. Genetic Signatures’ flexible syndromic approach provides a timely and accurate diagnosis that enhances efficiencies within the laboratory. Customers trust Genetic Signatures’ assay and workflow reliability which is supported by the Company’s high service standards and genuine partnership for driving improved patient outcomes. Genetic Signatures’ EasyScreen™ products are accessible in over 30 countries, with direct representation in the United States, United Kingdom, Germany, and Australia, and distribution partners in Canada, South America, Africa and other European nations. Products are used for IVD use and research purposes. As an employer, Genetic Signatures is proud of their highly rated and diverse workplace culture, and is committed to providing equal employment opportunities and professional development. Visit www.geneticsignatures.com for more information or email marketing@geneticsignatures.com to contact your local specialist. #moleculardiagnostics #pathology #PCR #multiplex #infectiousdisease #3base
Employees by Management Level
Total employees: 101-200
Seniority
Employees
Employees by Department
Genetic Signatures has 47 employees across 13 departments.
Departments
Number of employees
Funding Data
Genetic Signatures has never raised funding before.
Genetic Signatures Tech Stack
Discover the technologies and tools that power Genetic Signatures's digital infrastructure, from frameworks to analytics platforms.
Video players
Security
JavaScript libraries
JavaScript libraries
Cookie compliance
JavaScript libraries
Maps
JavaScript libraries
JavaScript libraries
CDN
Marketing automation
United Kingdom
Germany
Finland
SwitzerlandFrequently asked questions
4.8
40,000 users
